Devang Mehta of Anand Rathi Financial Services is of the view that CARE may test Rs 2100-2200.
Devang Mehta of Anand Rathi Financial Services told CNBC-TV18, "Couples of ideas that immediately come to our mind are we just initiated a report six–seven days back on Credit Analysis and Research (CARE) ratings. This could in fact be a big beneficiary as soon as the gross domestic product (GDP) growth starts coming and lot of debt issuances as well as equity issuances come into picture and this is a fantastic business model and trading at a relative discount to CRISIL and ICRA. So we feel there is a substantial upside for CARE. As it is also expanding in the hinterland of India, so could probably have a target of around Rs 2,100 -2,200."
"Another stock that we like in the water management space is VA Tech Wabag which is relatively a smaller size stock of around Rs 4,500 crore market cap. However a big pie could be garnered by this company and again it is a MNC type of a company with zero debt, so lot of opportunities are coming its way," he said.The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .